Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Sentinel lymph node biopsy in patients with thick primary cutaneous melanoma: patterns of use and underuse utilizing a population-based model.

Martinez SR, Shah DR, Yang AD, Canter RJ, Maverakis E.

ISRN Dermatol. 2013;2013:315609. doi: 10.1155/2013/315609. Epub 2013 Jan 10.

2.

Sentinel lymph node biopsy followed by lymph node dissection for localised primary cutaneous melanoma.

Kyrgidis A, Tzellos T, Mocellin S, Apalla Z, Lallas A, Pilati P, Stratigos A.

Cochrane Database Syst Rev. 2015 May 16;(5):CD010307. doi: 10.1002/14651858.CD010307.pub2. Review.

PMID:
25978975
3.

Assessing rural-urban disparities in the use of sentinel lymph node biopsy for melanoma.

Shah DR, Yang AD, Maverakis E, Martinez SR.

J Surg Res. 2013 Oct;184(2):1157-60. doi: 10.1016/j.jss.2013.04.091. Epub 2013 Jun 6.

PMID:
23768765
4.

Geographic variation in utilization of sentinel lymph node biopsy for intermediate thickness cutaneous melanoma.

Martinez SR, Shah DR, Maverakis E, Yang AD.

J Surg Oncol. 2012 Dec;106(7):807-10. doi: 10.1002/jso.23169. Epub 2012 Jun 4.

5.

Sentinel Lymph Node Biopsy Provides Prognostic Value in Thick Head and Neck Melanoma.

Monroe MM, Pattisapu P, Myers JN, Kupferman ME.

Otolaryngol Head Neck Surg. 2015 Sep;153(3):372-8. doi: 10.1177/0194599815589948. Epub 2015 Jun 12.

PMID:
26070510
6.

Age-related disparities in use of completion lymphadenectomy for melanoma sentinel lymph node metastasis.

Shah DR, Yang AD, Maverakis E, Martinez SR.

J Surg Res. 2013 Nov;185(1):240-4. doi: 10.1016/j.jss.2013.05.090. Epub 2013 Jun 19.

PMID:
23809182
7.

Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005).

Chen AY, Halpern MT, Schrag NM, Stewart A, Leitch M, Ward E.

J Natl Cancer Inst. 2008 Apr 2;100(7):462-74. doi: 10.1093/jnci/djn057. Epub 2008 Mar 25.

PMID:
18364506
8.

Sentinel lymph node biopsy for cutaneous melanoma: the Stanford experience, 1997-2004.

Berk DR, Johnson DL, Uzieblo A, Kiernan M, Swetter SM.

Arch Dermatol. 2005 Aug;141(8):1016-22.

PMID:
16103331
9.

Cervical sentinel lymph node biopsy for melanomas of the head and neck and upper thorax.

Wagner JD, Park HM, Coleman JJ 3rd, Love C, Hayes JT.

Arch Otolaryngol Head Neck Surg. 2000 Mar;126(3):313-21.

PMID:
10722003
10.

The prognostic importance of sentinel lymph node biopsy in thin melanoma.

Ranieri JM, Wagner JD, Wenck S, Johnson CS, Coleman JJ 3rd.

Ann Surg Oncol. 2006 Jul;13(7):927-32. Epub 2006 May 22.

PMID:
16788753
11.

Compliance with guidelines in the surgical management of cutaneous melanoma across the USA.

Wasif N, Gray RJ, Bagaria SP, Pockaj BA.

Melanoma Res. 2013 Aug;23(4):276-82. doi: 10.1097/CMR.0b013e32836254bd.

PMID:
23695440
12.

The complex relationships between sentinel node positivity, patient age, and primary tumor desmoplasia: analysis of 2303 melanoma patients treated at a single center.

Sassen S, Shaw HM, Colman MH, Scolyer RA, Thompson JF.

Ann Surg Oncol. 2008 Feb;15(2):630-7. Epub 2007 Dec 14.

PMID:
18080717
13.

Sentinel node biopsy for head and neck desmoplastic melanoma: not a given.

Eppsteiner RW, Swick BL, Milhem MM, Hoffman HT, Pagedar NA.

Otolaryngol Head Neck Surg. 2012 Aug;147(2):271-4. doi: 10.1177/0194599812439857. Epub 2012 Mar 7.

PMID:
22399279
14.

Health care system and socioeconomic factors associated with variance in use of sentinel lymph node biopsy for melanoma in the United States.

Bilimoria KY, Balch CM, Wayne JD, Chang DC, Palis BE, Dy SM, Lange JR.

J Clin Oncol. 2009 Apr 10;27(11):1857-63. doi: 10.1200/JCO.2008.18.7567. Epub 2009 Mar 9.

PMID:
19273706
15.

Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma.

Sabel MS, Griffith K, Sondak VK, Lowe L, Schwartz JL, Cimmino VM, Chang AE, Rees RS, Bradford CR, Johnson TM.

J Am Coll Surg. 2005 Jul;201(1):37-47.

PMID:
15978442
16.

Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma.

Wagner JD, Gordon MS, Chuang TY, Coleman JJ 3rd, Hayes JT, Jung SH, Love C.

Cancer. 2000 Jul 15;89(2):453-62.

PMID:
10918179
17.

The effect of the AJCC 7th edition change in T1 melanoma substaging on national utilization and outcomes of sentinel lymph node biopsy for thin melanoma.

Hieken TJ, Grotz TE, Comfere NI, Inselman JW, Habermann EB.

Melanoma Res. 2015 Apr;25(2):157-63. doi: 10.1097/CMR.0000000000000143.

PMID:
25647736
18.

Sentinel lymph node biopsy for melanoma: indications and rationale.

Phan GQ, Messina JL, Sondak VK, Zager JS.

Cancer Control. 2009 Jul;16(3):234-9. Review.

19.

Completion node dissection in patients with sentinel node-positive melanoma of the head and neck.

Smith VA, Cunningham JE, Lentsch EJ.

Otolaryngol Head Neck Surg. 2012 Apr;146(4):591-9. doi: 10.1177/0194599811432672. Epub 2012 Jan 11.

PMID:
22237296
20.

Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.

Niakosari F, Kahn HJ, McCready D, Ghazarian D, Rotstein LE, Marks A, Kiss A, From L.

Arch Dermatol. 2008 Apr;144(4):462-7. doi: 10.1001/archderm.144.4.462.

PMID:
18427039

Supplemental Content

Support Center